Business Wire1h
Contineum Therapeutics Expands Clinical Development of PIPE-791 With FDA Authorization of Its Investigational New Drug (IND) Application for Chronic Pain
Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical stage biopharmaceutical company focused on discovering and developi ...
Krone7h
Pain? Recognize complaints during a walk
Pain when walking? A research group at the Carinthia University of Applied Sciences is working on detecting physical ...